Download | < Back |
23 May 2024 | |
Disclosure under Regulation 30 of the SEBI (listing Obligations and DIsclsoure Requirements) Regulations, 2015 - Successful closure of US FDA Inspection of Piramal Pharma''s manufacturing facility located at Lexington, USA. | |
View all announcements for Piramal Pharma Ltd | Source: BSE India |